|
|
Article: Farmhouse Equity Research LLC Initiates Buy Rating on DOR BioPharma.
- Article from:
- Business Wire
- Article date:
- February 3, 2003
CopyrightCOPYRIGHT 2003 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health & Medical Writers
LAKE FOREST, Ill.--(BUSINESS WIRE)--Feb. 3, 2003
DOR BioPharma Inc. (AMEX:DOR) ("DOR") announced that Farmhouse Equity Research, LLC has initiated research coverage on the Company with a buy rating.
The research report can be accessed by contacting J.P. Mark, President & Senior Managing Director at jpmark@feqr.com.
About Farmhouse Equity Research, LLC
Farmhouse Equity Research, LLC strives to produce the highest quality independent equity research available. Our name is emblematic of the services we provide: hard work backed up by honesty, integrity and consistency. Our focus is on ...
Related newspaper, magazine, and journal articles:
|
|
Article: DOR BioPharma Presents Advancements Of Its Oral ...
Business Wire;
December 21, 2001 ;
700+ words
... ... BW HealthWire)--Dec. 21, 2001 DOR BioPharma, Inc. (AMEX:DOR) announced results ... as an injectable depot formulation. DOR BioPharma is developing an oral formulation of ... Panos Constantinides, Ph.D., DOR BioPharma Vice President of Research and Development ...
|
|